Omnicell Inc
Change company Symbol lookup
Select an option...
OMCL Omnicell Inc
BOAS BOA Acquisition Corp
ESBA Empire State Realty OP LP
ASGN ASGN Inc
CMS CMS Energy Corp
POWRU Powered Brands
VLDRW Velodyne Lidar Equity Warrants Exp 29 Sep 2025 *W EXP 09/29/2025
JPM JPMorgan Chase & Co
UVV Universal Corp
LNC Lincoln National Corp
Go

Health Care : Health Care Technology | Small Cap Growth
Company profile

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. Its point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility’s in-house information management systems. Its Central Pharmacy IV Compounding Service offers a comprehensive service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.

Closing Price
$145.69
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
337,434
0

OMCL's position in the Health Care Technology industry

Industry PeersOMCLCERN

Summary

Company ProfileOmnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through...
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and technology enabled services that support the clinical...
Go to CERN summary
52-Week Change

VS. INDUSTRY
22.45%
13.29%
Market Cap

VS. INDUSTRY
$6.4B
$26.7B
Beta

VS. INDUSTRY
1.1
0.8
Dividend Yield

VS. INDUSTRY
--
1.18%
P/E (TTM, GAAP)

VS. INDUSTRY
84.86x
53.34x
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$1.1B
$5.7B
Profit Margin

VS. INDUSTRY
7.50%
9.15%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
-2.56%
10.42%
Revenue Growth (TTM)

VS. INDUSTRY
20.07%
2.78%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.